Real-world application of surufatinib in the treatment of neuroendocrine tumors: a multi-center retrospective study in China
Abstract Recently, the incidence of neuroendocrine tumors (NETs), characterized by neuroendocrine differentiation, has increased. Their heterogeneous origins and biological behaviors complicate diagnosis and treatment. Surufatinib, a novel oral tyrosine kinase inhibitor with dual anti-angiogenic and...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-12-01
|
| Col·lecció: | European Journal of Medical Research |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s40001-025-03567-3 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|